JP2008539782A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008539782A5 JP2008539782A5 JP2008511868A JP2008511868A JP2008539782A5 JP 2008539782 A5 JP2008539782 A5 JP 2008539782A5 JP 2008511868 A JP2008511868 A JP 2008511868A JP 2008511868 A JP2008511868 A JP 2008511868A JP 2008539782 A5 JP2008539782 A5 JP 2008539782A5
- Authority
- JP
- Japan
- Prior art keywords
- marker
- cancer
- prostate cancer
- haplotype
- allele
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 29
- 239000003550 marker Substances 0.000 claims 24
- 206010060862 Prostate cancer Diseases 0.000 claims 19
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 19
- 102000054766 genetic haplotypes Human genes 0.000 claims 16
- 206010028980 Neoplasm Diseases 0.000 claims 12
- 201000011510 cancer Diseases 0.000 claims 11
- 108700028369 Alleles Proteins 0.000 claims 10
- 201000001441 melanoma Diseases 0.000 claims 5
- 206010006187 Breast cancer Diseases 0.000 claims 3
- 208000026310 Breast neoplasm Diseases 0.000 claims 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 3
- 239000003153 chemical reaction reagent Substances 0.000 claims 3
- 201000005202 lung cancer Diseases 0.000 claims 3
- 208000020816 lung neoplasm Diseases 0.000 claims 3
- 230000000295 complement effect Effects 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 230000035945 sensitivity Effects 0.000 claims 2
- 210000001082 somatic cell Anatomy 0.000 claims 2
- 230000003321 amplification Effects 0.000 claims 1
- 230000008709 cellular rearrangement Effects 0.000 claims 1
- 208000030381 cutaneous melanoma Diseases 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 208000035392 hereditary 6 prostate cancer Diseases 0.000 claims 1
- 208000032154 hereditary 8 prostate cancer Diseases 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 230000003211 malignant effect Effects 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- 238000004393 prognosis Methods 0.000 claims 1
- 230000000750 progressive effect Effects 0.000 claims 1
- 201000003708 skin melanoma Diseases 0.000 claims 1
- 230000005945 translocation Effects 0.000 claims 1
- 238000011277 treatment modality Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68214705P | 2005-05-18 | 2005-05-18 | |
| US60/682,147 | 2005-05-18 | ||
| US79576806P | 2006-04-28 | 2006-04-28 | |
| US60/795,768 | 2006-04-28 | ||
| PCT/IS2006/000012 WO2006123369A1 (en) | 2005-05-18 | 2006-05-18 | Variants at chr8q24.21 confer risk of cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008539782A JP2008539782A (ja) | 2008-11-20 |
| JP2008539782A5 true JP2008539782A5 (enExample) | 2009-07-30 |
| JP5227167B2 JP5227167B2 (ja) | 2013-07-03 |
Family
ID=36830953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008511868A Expired - Fee Related JP5227167B2 (ja) | 2005-05-18 | 2006-05-18 | Ｃｈｒ８ｑ２４．２１での変異体は癌のリスクを与える |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090317799A1 (enExample) |
| EP (1) | EP1888772A1 (enExample) |
| JP (1) | JP5227167B2 (enExample) |
| AU (1) | AU2006248591B2 (enExample) |
| BR (1) | BRPI0610794A2 (enExample) |
| CA (1) | CA2608567A1 (enExample) |
| IL (1) | IL187449A (enExample) |
| MX (1) | MX2007014447A (enExample) |
| NZ (1) | NZ563913A (enExample) |
| WO (1) | WO2006123369A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2677994A1 (en) * | 2007-02-07 | 2008-08-14 | Decode Genetics Ehf. | Genetic variants contributing to risk of prostate cancer |
| EP2164984A2 (en) * | 2007-05-25 | 2010-03-24 | Decode Genetics EHF. | Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment |
| US8697360B2 (en) * | 2007-11-30 | 2014-04-15 | Decode Genetics Ehf. | Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition |
| US20090226912A1 (en) * | 2007-12-21 | 2009-09-10 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| US9732389B2 (en) | 2010-09-03 | 2017-08-15 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| US9534256B2 (en) | 2011-01-06 | 2017-01-03 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer |
| WO2013065072A1 (en) * | 2011-10-30 | 2013-05-10 | Decode Genetics Ehf | Risk variants of prostate cancer |
| KR101944927B1 (ko) | 2016-03-24 | 2019-02-07 | 서울대학교산학협력단 | 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발 |
| KR20250074712A (ko) | 2023-11-15 | 2025-05-28 | 주식회사 바스젠바이오 | 전립선암 발병의 위험도를 예측하기 위한 조성물 및 이를 이용한 방법 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| FI843529A0 (fi) | 1983-01-10 | 1984-09-10 | Gen Probe Inc | Foerfarande foer detektering, identifiering och kvantitering av organismer och virus. |
| US5288611A (en) | 1983-01-10 | 1994-02-22 | Gen-Probe Incorporated | Method for detecting, identifying, and quantitating organisms and viruses |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
| US5288644A (en) | 1990-04-04 | 1994-02-22 | The Rockefeller University | Instrument and method for the sequencing of genome |
| DE69132531T2 (de) | 1990-12-06 | 2001-09-13 | Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) | Verbindungen und ihre Verwendung in einer binären Synthesestrategie |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| EP0655090B1 (en) | 1992-04-27 | 2000-12-27 | The Trustees Of Dartmouth College | Detection of gene sequences in biological fluids |
| WO1999032644A2 (en) * | 1997-12-22 | 1999-07-01 | Genset | Prostate cancer gene |
-
2006
- 2006-05-18 BR BRPI0610794-0A patent/BRPI0610794A2/pt not_active IP Right Cessation
- 2006-05-18 JP JP2008511868A patent/JP5227167B2/ja not_active Expired - Fee Related
- 2006-05-18 EP EP06728429A patent/EP1888772A1/en not_active Withdrawn
- 2006-05-18 US US11/920,590 patent/US20090317799A1/en not_active Abandoned
- 2006-05-18 WO PCT/IS2006/000012 patent/WO2006123369A1/en not_active Ceased
- 2006-05-18 CA CA002608567A patent/CA2608567A1/en not_active Abandoned
- 2006-05-18 AU AU2006248591A patent/AU2006248591B2/en not_active Ceased
- 2006-05-18 NZ NZ563913A patent/NZ563913A/en not_active IP Right Cessation
- 2006-05-18 MX MX2007014447A patent/MX2007014447A/es active IP Right Grant
-
2007
- 2007-11-18 IL IL187449A patent/IL187449A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Association analysis of IL-17A and IL-17F polymorphisms in Chinese Han women with breast cancer | |
| Lynch et al. | Screening for familial and hereditary prostate cancer | |
| TW200949249A (en) | Methods, agents and kits for the detection of cancer | |
| Hofer et al. | Association of genetic variants of human telomerase with colorectal polyps and colorectal cancer risk | |
| Ma et al. | First evidence for the contribution of the genetic variations of BRCA1-interacting protein 1 (BRIP1) to the genetic susceptibility of cervical cancer | |
| Nikolić et al. | Association between genetic variant in hsa-miR-146a gene and prostate cancer progression: evidence from Serbian population | |
| Chan et al. | 8q24 and 17q prostate cancer susceptibility loci in a multiethnic Asian cohort | |
| JP2008539782A5 (enExample) | ||
| KR101582723B1 (ko) | 대장암 발병 위험도 예측을 위한 유전 마커와 이의 이용 | |
| Guo et al. | Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer | |
| JP2012517242A5 (enExample) | ||
| Zhang et al. | Prostate cancer susceptibility loci identified in GATA2 and ZMIZ1 in Chinese population | |
| KR20110106244A (ko) | 간세포암종의 예후 진단용 단일 염기 다형성 | |
| KR102195593B1 (ko) | Ddc의 다형성을 이용한 소세포폐암의 예후 진단 방법 | |
| Krawczyk et al. | Macrophage stimulating protein variation enhances the risk of sporadic extrahepatic cholangiocarcinoma | |
| TWI479024B (zh) | 檢測ｐ／ｐ血型的方法及其檢測套組 | |
| Jung et al. | TNFα promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population | |
| WO2012108527A1 (ja) | 肝細胞癌への進展予測マーカー | |
| WO2008121825A3 (en) | Epidermal growth factor (egf) expression and/or polymorphisms thereof for predicting the risk of developing cancer | |
| JP6915804B2 (ja) | イリノテカンの治療効果予測方法及びそのためのキット | |
| KR101806025B1 (ko) | 비소세포폐암 환자의 항암제 치료 반응성 및 예후 예측용 ｓｎｐ 마커 및 이의 용도 | |
| KR101819795B1 (ko) | 대장암 발병 진단 및 예측용 유전 마커 | |
| Al-Husseini et al. | Assess the contribution of ribosomal RNA processing 1B gene polymorphisms in breast cancer in Iraqi patients. | |
| AU2017270496B2 (en) | Determination of genetic predisposition to aggressive prostate cancer | |
| Wang et al. | Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma |